Women's Hair Care
Specialised diagnosis and treatment for women's hair thinning and hair loss. Ludwig scale assessment, hormonal evaluation, and personalised treatment plans by board-certified female dermatologists at DermaVue.
Ludwig Classification
Female pattern hair loss is classified using the Ludwig scale. Unlike men, women typically retain their frontal hairline but experience progressive thinning on the crown.
Noticeable thinning along the central hair part. Hair density appears slightly reduced on the crown. Easily concealed with styling. Often the first sign noticed during hair washing.
PRP + MedicationsPronounced widening of the central part with visible scalp. Noticeable volume reduction across the crown area. Hair appears thin when pulled back. Styling can no longer fully conceal.
GFC + PRP + MedicationsNear-complete thinning on the crown with clearly visible scalp. Only a thin band of hair may remain at the frontal hairline. Significant impact on appearance and confidence.
Transplant + PRP + MedicationsWhy It Happens
Women experience hair loss differently from men. Understanding your specific cause is essential for effective treatment.
Genetic sensitivity to androgens causes progressive follicle miniaturisation. The most common cause in women over 40, but can start in the 20s. Presents as diffuse thinning, not receding hairline.
Elevated androgen levels from PCOS cause scalp hair thinning while increasing facial/body hair. Thyroid dysfunction (both hypo and hyper) also triggers significant shedding.
Postpartum hair shedding (telogen gravidarum) affects 50% of women 2–4 months after delivery. Caused by rapidly falling oestrogen levels. Usually temporary but can be distressing.
Heavy menstruation, vegetarian diets, and poor absorption lead to low ferritin levels — one of the most treatable causes of female hair loss. DermaVue tests serum ferritin in every female patient.
Physical or emotional stress, crash diets, surgery, or illness pushes hair follicles into resting phase. Causes diffuse shedding 2–3 months after the triggering event. Reversible with treatment.
Declining oestrogen and progesterone during perimenopause and menopause accelerate hair thinning. Hair follicle diameter decreases, leading to visibly finer, thinner hair.
Solutions
Personalised treatment plans combining the most effective therapies for female hair loss. All procedures performed by board-certified dermatologists.
Your own platelet-rich plasma injected into the scalp to reactivate dormant follicles. Highly effective for Ludwig Grade I–II with minimal downtime.
Growth Factor Concentrate delivers 5x more growth factors than standard PRP. Fewer sessions needed, reduced discomfort, and faster visible results.
Direct micro-injection of vitamins, minerals, and amino acids into the scalp. Nourishes follicles at the mesoderm level. Ideal for nutritional deficiency-related hair loss.
FDA-approved 2% topical solution for women. Prolongs hair growth phase and increases follicle diameter. Applied daily at home as part of your dermatologist-guided regimen.
Targeted supplementation of iron, vitamin D, biotin, zinc, and omega-3 based on blood test results. Addresses deficiency-driven hair loss at its root cause.
FDA-cleared photobiomodulation stimulates cellular energy in hair follicles. Non-invasive, painless, and can be combined with PRP/GFC for enhanced results.
Free Consultation
Book a free trichoscopy consultation with our dermatologists. Get a personalised diagnosis, Ludwig scale grading, and treatment plan — with zero obligation.
Visit Us
Common Questions
The most common causes include Female Pattern Hair Loss (FPHL, genetic), hormonal changes (PCOS, thyroid disorders, menopause, post-pregnancy), iron deficiency anaemia, vitamin D deficiency, telogen effluvium from stress or illness, alopecia areata (autoimmune), traction alopecia from tight hairstyles, and certain medications. At DermaVue, our dermatologists perform comprehensive blood work and trichoscopy to identify the specific cause before recommending treatment.
Many types of female hair loss are reversible with proper treatment. Telogen effluvium often resolves on its own or with addressing the trigger. Nutritional deficiency-related hair loss reverses with supplementation. FPHL can be managed and improved with PRP, GFC, minoxidil, and mesotherapy — though genetic hair loss requires ongoing treatment to maintain results. DermaVue dermatologists see measurable improvement in 80% of female patients within 6 months of treatment.
The Ludwig scale classifies female pattern hair loss into three grades: Grade I (mild) — noticeable thinning along the central part. Grade II (moderate) — pronounced widening of the part with visible scalp and decreased volume. Grade III (extensive) — near-complete thinning on the crown. Unlike male pattern baldness, women typically retain their frontal hairline. Your DermaVue dermatologist grades your hair loss during trichoscopy consultation.
Yes, PRP is highly effective for female hair loss and is one of DermaVue's most recommended treatments for women. PRP stimulates dormant follicles, increases blood supply, and promotes new growth without systemic side effects. It is particularly effective for Ludwig Grade I–II FPHL and telogen effluvium. Most women see visible improvement after 3–4 sessions. DermaVue also offers GFC, an advanced version with higher growth factor concentration.
Topical minoxidil 2% is FDA-approved and safe for women with FPHL. It prolongs the growth phase (anagen) and increases follicle size. Results are typically visible after 3–6 months. Women should use 2% concentration (not 5%, which is for men). Oral minoxidil in low doses may also be prescribed for non-responders. Your DermaVue dermatologist will monitor and adjust treatment as needed.
Yes, women can get FUE hair transplants for specific indications: stable FPHL with good donor density, hairline lowering or reshaping, scar camouflage, and permanent traction alopecia. DermaVue dermatologists carefully assess donor area density before recommending transplant. Many women achieve excellent results with non-surgical treatments (PRP, GFC, medications) without needing transplant surgery.
PCOS causes hair loss through elevated androgen levels, particularly testosterone and DHT. Excess androgens shrink scalp hair follicles (miniaturisation) while potentially increasing facial/body hair. Treatment at DermaVue addresses both the hormonal cause (in coordination with your gynaecologist) and the hair loss through PRP, GFC, anti-androgen medications, and topical treatments.
PRP sessions ₹3,000–₹5,000 each (4–6 recommended), GFC treatment ₹5,000–₹8,000 per session, mesotherapy ₹2,500–₹4,000 per session. A complete 6-month treatment plan typically ranges from ₹20,000–₹50,000 depending on the combination needed. 0% EMI financing is available. The initial consultation and trichoscopy assessment are free at all 7 DermaVue branches.